© 2022 MJH Life Sciences and Ophthalmology Times. All rights reserved.
© 2022 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
February 10, 2021
Investigators focus on biophysical method to study protein-protein interactions .
February 09, 2021
While current treatments are good, the best is yet to come.
February 08, 2021
Drops can simplify dosing, improving adherence and ocular surface health
February 05, 2021
Consider ideas about outflow pathways, neuroprotection.
February 04, 2021
Investigators examine long-term effects of therapeutics in infants.
February 02, 2021
Peptides offering ophthalmologists a potential treatment option for keratitis.
February 01, 2021
Once-daily corticosteroid treats pain, inflammation after surgery.
January 29, 2021
Noninvasive option reduces IOP in patients with glaucoma.
January 28, 2021
Community involvement, research continue to boost treatment in pediatric population.
January 27, 2021
Emerging technology may facilitate individualized care, disease management.
January 26, 2021
Organization shines spotlight on frontline heroes during ongoing COVID-19 battle.
January 25, 2021
For ophthalmologists, practice makes perfect in becoming ambidextrous.
January 22, 2021
Physician pioneers technique offering higher perspective in surgery, outcomes.
January 20, 2021
Sometimes, physicians may find that falling behind is the right thing to do.
January 14, 2021
Check out the latest cartoon!
January 05, 2021
Minimally invasive conjunctival surgery option is an efficient procedure.
January 03, 2021
Study supports preoperative ocular surface optimization with artificial tears.
December 31, 2020
All syringes used for intravitreal injections have pros and cons. Some recently marketed and forthcoming products are coming closer to meeting “ideal” criteria.
Novel MIGS stent technology boasts robust IOP-lowering effect in open-angle glaucoma
Donation bolsters Vanderbilt’s work in retinal vision research
AAO LIVE: Robot-assisted procedures may be the future of MIGS